thiazolyl blue has been researched along with paclitaxel in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (9.30) | 18.2507 |
2000's | 28 (65.12) | 29.6817 |
2010's | 10 (23.26) | 24.3611 |
2020's | 1 (2.33) | 2.80 |
Authors | Studies |
---|---|
Asanuma, F; Hoshiya, Y; Kitajima, M; Koh, JI; Kubota, T; Matsuzaki, SW; Watanabe, M; Yamada, Y | 1 |
Hirota, Y; Iimura, S; Ishiyama, T; Mitsui, I; Ohsuki, S; Soga, T; Takenoshita, H; Terasawa, H; Uoto, K | 1 |
Passaniti, A; Wang, W | 1 |
Hamaguchi, Y; Hasegawa, S; Hisatomi, H; Ichikawa, Y; Ishikawa, T; Kamiyama, M; Momiyama, N; Narita, T; Shimada, H | 1 |
Chao, Y; Chen, LT; Huang, TS; Shu, CH | 1 |
Ando, Y; Bates, SE; Blagosklonny, MV; Figg, WD; Fojo, T; Kang, MH; Liewehr, D | 1 |
Chi, K; Conklin, BS; Cooper, S; Gleave, ME; Miyake, H; Monia, BP; Zellweger, T | 1 |
Fan, Z; Schmidt, M | 1 |
Kim, JY; Kim, SH; Kim, YS; Lee, HJ; Lee, KW; Wee, JJ | 1 |
Alila, H; Baron, A; Bunn, PA; Chan, DC; Earle, KA; Helfrich, B; Nelson, P; Pamukcu, R; Piazza, G; Thompson, WJ; Whitehead, CM; Zeng, C; Zhao, TL | 1 |
Duan, Z; Kronish, KM; Lamendola, DE; Penson, RT; Seiden, MV | 1 |
Akeshima, R; Iba, T; Itamochi, H; Kamazawa, S; Kanamori, Y; Kigawa, J; Sultana, H; Terakawa, N | 1 |
Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Saydam, G; Sezgin, C; Uslu, R | 1 |
Blumenthal, RD; Goldenberg, DM; Leone, E; Modrak, D; Rodriguez, M | 1 |
Gabbert, HE; Gerharz, CD; Reinecke, P; Schmitz, M; Steckstor, M | 1 |
Beraldi, E; English, JC; Evans, K; Fazli, L; Gleave, ME; July, LV; So, A | 1 |
Kalb, EN; Lazo, JS; Vogt, A | 1 |
Emami, A; Gordon, JD; Park, SJ; Safa, AR; Wu, CH; Zhong, X | 1 |
Banks, RE; Ferguson, RE; Harnden, P; Jackson, SM; Joyce, AD; Morrison, EE; Patel, PM; Phillips, RM; Selby, PJ; Stanley, AJ | 1 |
Alsina, M; Beam, C; Beaupre, DM; Dalton, W; Gerbino, E; Hamilton, AD; Kerr, WG; Lichtenheld, MG; Mackley, PA; Muro-Cacho, C; Sebti, SM; Zhu, K | 1 |
Chen, SZ; Jiang, M; Zhen, YS | 1 |
Kim, CJ; Lee, KH; Namkoong, SE; Park, JS; Um, SJ; Yim, EK | 1 |
Götz, C; Harlozinska, A; Kartarius, S; Montenarh, M; Touma, R | 1 |
Cho, JS; Choi, HJ; Han, BH; Pyo, SH | 1 |
Dong, Y; Feng, SS | 1 |
Chen, G; Guo, L; Liu, J; Wang, Y; Yin, F; Zheng, X | 1 |
Lei, P; Li, W; Shao, J; Shen, G; Wang, X; Yang, J; Ye, Q; Zhang, Y; Zhu, H | 1 |
Ma, D; Ma, X; Meng, L; Song, X; Wang, S; Weng, D; Weng, Y; Xia, X; Xing, H; Xu, G; Zhou, J; Zhu, T | 1 |
Chuang, YC; Huang, H; Huang, HC; Wang, HJ | 1 |
Fukushima, M; Konishi, K; Okada, M; Sanada, Y; Tsutani, Y; Wada, Y; Yoshida, K | 1 |
Chen, X; Jing, X; Wang, Z; Xu, X | 1 |
Ashby, CR; Chen, A; Chen, X; Chen, ZS; Hopper-Borge, E; Kuang, YH; Lei, Y; Ouyang, J; Shen, T; Tiwari, AK; Zhou, Y | 1 |
Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinoshita, J; Kinuya, S; Ninomiya, I; Ohta, T; Oyama, K; Tsukada, T; Yagi, Y; Yashiro, M | 1 |
Han, L; Jia, ZF; Kang, CS; Mei, M; Pu, PY; Ren, Y; Wang, GX; Xu, P; Yuan, XB; Zhou, X | 1 |
Arduino, DM; Cardoso, SM; Esteves, AR; Oliveira, CR; Silva, DF | 1 |
Chen, WL; Guo, SR; Lei, L; Rong, HJ; Shen, YY | 1 |
Bowen, WD; Cao, C; Hsu, CH; Kim, JH; Marshall, J; Wanebo, HJ; Wu, CH; Xu, J | 1 |
Chen, J; Du, QH; Mu, LH; Niu, XH; Wang, P; Zhang, MY | 1 |
Hoye, TR; Kalscheuer, S; Macosko, CW; Michel, AR; Panyam, J; Wohl, AR | 1 |
Kala, S; Liu, X; Mak, AS; Peng, L; Posocco, P; Pricl, S; Wong, AS | 1 |
Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
Han, K; Xie, Y; Yang, Y | 1 |
Cui, F; Han, Y; Kawashima, Y; Li, S; Liang, N; Liu, J; Sun, S; Yan, P | 1 |
1 trial(s) available for thiazolyl blue and paclitaxel
Article | Year |
---|---|
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bilirubin; Chromatography, High Pressure Liquid; Coloring Agents; Cyclosporins; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Microsomes, Liver; Models, Chemical; Paclitaxel; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors | 2001 |
42 other study(ies) available for thiazolyl blue and paclitaxel
Article | Year |
---|---|
Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Coloring Agents; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Paclitaxel; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coloring Agents; Crystallography, X-Ray; Docetaxel; Humans; Mass Spectrometry; Mice; Microtubules; Paclitaxel; Structure-Activity Relationship; Swine; Taxoids; Tetrazolium Salts; Thiazoles; Tubulin; Tumor Cells, Cultured | 1997 |
Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NfkappaB-dependent mechanism.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Differentiation; Cell Line; Cell Nucleus; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoplasm; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Etoposide; Extracellular Matrix; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Nucleic Acid Synthesis Inhibitors; Oligonucleotides, Antisense; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Tetrazolium Salts; Thiazoles; Time Factors; Transfection | 1999 |
Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinoma; Cell Count; Cell Division; Cell Survival; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Electrophoresis, Agar Gel; Female; Fluorouracil; Gene Expression; Humans; Paclitaxel; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Taxoids; Telomerase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1999 |
Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Carrier Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cyclin B; Cyclin B1; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Etoposide; Flow Cytometry; Fungal Proteins; Humans; Nasopharyngeal Neoplasms; Nuclear Proteins; Paclitaxel; Precipitin Tests; Protein Kinases; Tetrazolium Salts; Thiazoles; Toxicity Tests; Tumor Cells, Cultured | 2001 |
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Northern; Clusterin; Electrophoresis, Capillary; Glycoproteins; Half-Life; Humans; Male; Mice; Molecular Chaperones; Neoplasm Proteins; Oligonucleotides, Antisense; Paclitaxel; Prostatic Neoplasms; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Topics: Cell Cycle Proteins; Cell Division; Cisplatin; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA Mutational Analysis; DNA, Complementary; Dose-Response Relationship, Drug; Ecdysone; Enzyme Inhibitors; Flow Cytometry; Humans; Immunoblotting; Mutation; Paclitaxel; Phosphorylation; Promoter Regions, Genetic; Retinoblastoma Protein; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |
Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriol.
Topics: 3T3 Cells; Alkynes; Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; DNA, Neoplasm; Dose-Response Relationship, Drug; Enediynes; Fatty Alcohols; Flow Cytometry; G2 Phase; Humans; Jurkat Cells; K562 Cells; Medicine, East Asian Traditional; Mice; Mitosis; Molecular Structure; Paclitaxel; Panax; Plant Extracts; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; U937 Cells | 2002 |
Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Docetaxel; Drug Administration Schedule; Female; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mediastinal Neoplasms; Neoplasms, Experimental; Paclitaxel; Rats; Rats, Nude; Sulindac; Survival Rate; Taxoids; Tetrazolium Salts; Thiazoles | 2002 |
Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Caspase 3; Caspases; Cell Division; DNA, Complementary; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Genetic Vectors; Humans; Interleukin-6; Interleukin-8; Mitoxantrone; Osteosarcoma; Paclitaxel; Phenotype; RNA; Tetrazolium Salts; Thiazoles; Time Factors; Topotecan; Transfection; Tumor Cells, Cultured | 2002 |
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Coloring Agents; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Inhibitory Concentration 50; Irinotecan; Mitochondrial Proteins; Mitomycin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
Which dosing scheme is suitable for the taxanes? An in vitro model.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Division; Cell Survival; Docetaxel; Female; Humans; Indicators and Reagents; Paclitaxel; Taxoids; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression.
Topics: Antineoplastic Agents; Carboplatin; Cell Division; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Resistance, Neoplasm; Drug Synergism; Female; Genetic Therapy; Humans; In Vitro Techniques; Mutation; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Yttrium Radioisotopes | 2004 |
Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Separation; Cell Survival; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Heart Neoplasms; Histiocytoma, Benign Fibrous; Humans; Inhibitory Concentration 50; Paclitaxel; Phenotype; Plant Extracts; Soft Tissue Neoplasms; Tetrazolium Salts; Thiazoles; Vault Ribonucleoprotein Particles; Vincristine | 2004 |
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Northern; Cell Line, Tumor; Clusterin; Coloring Agents; Deoxycytidine; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Gemcitabine; Glycoproteins; Humans; Immunohistochemistry; In Vitro Techniques; Lung Neoplasms; Mice; Molecular Chaperones; Nucleotides; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Double-Stranded; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity.
Topics: Antineoplastic Agents; Bleomycin; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Shape; Formazans; Humans; Mitochondria; Paclitaxel; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2004 |
Taxol induces caspase-10-dependent apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carrier Proteins; Caspase 10; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Cell Culture Techniques; Cell Line; Cell Line, Tumor; Cell Survival; Coloring Agents; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Fas-Associated Death Domain Protein; Flow Cytometry; Genes, Dominant; Humans; Intracellular Signaling Peptides and Proteins; Membrane Potentials; Mitochondria; Mitochondrial Proteins; Models, Biological; Paclitaxel; Plasmids; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Type I; Tetrazolium Salts; Thiazoles; Transfection | 2004 |
Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Humans; Immunohistochemistry; Inhibitory Concentration 50; Kidney; Kidney Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Paclitaxel; Phenotype; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Time Factors; Tubulin; Up-Regulation; Vinblastine; Vincristine | 2005 |
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bone Marrow Cells; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cisplatin; Clinical Trials as Topic; Cytochromes c; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Enzyme Activation; Farnesyltranstransferase; Flow Cytometry; Fluorouracil; G2 Phase; Gemcitabine; Homozygote; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Mice; Mice, SCID; Mitosis; Multiple Myeloma; Paclitaxel; Quinolones; Taxoids; Tetrazolium Salts; Thiazoles | 2005 |
HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Biomarkers; Breast Neoplasms; Camptothecin; Carcinoma; Colonic Neoplasms; Coloring Agents; Drug Interactions; Drug Resistance, Neoplasm; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Expression Profiling; Humans; Lung Neoplasms; Paclitaxel; Potassium Channels, Voltage-Gated; Tetrazolium Salts; Thiazoles; Transfection; Vincristine | 2005 |
Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Cycle Proteins; Electrophoresis, Gel, Two-Dimensional; Female; HeLa Cells; Humans; Paclitaxel; Poly-ADP-Ribose Binding Proteins; Proteomics; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrazolium Salts; Thiazoles; Transfection; Uterine Cervical Neoplasms | 2005 |
Growth inhibition and apoptosis induction in ovarian cancer cells.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Female; Gemcitabine; Genes, p53; Humans; Ovarian Neoplasms; Paclitaxel; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2006 |
Evaluation of paclitaxel rearrangement involving opening of the oxetane ring and migration of acetyl and benzoyl groups.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Indicators and Reagents; KB Cells; Magnetic Resonance Spectroscopy; Paclitaxel; Tetrazolium Salts; Thiazoles | 2007 |
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Survival; Chromatography, High Pressure Liquid; Coumarins; Drug Compounding; Fluorescent Dyes; Glioma; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pressure; Tetrazolium Salts; Thiazoles | 2007 |
Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Doxorubicin; Female; HeLa Cells; Humans; Indicators and Reagents; Mice; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma 180; Telomerase; Tetrazolium Salts; Thiazoles; Trientine | 2008 |
Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Flow Cytometry; HL-60 Cells; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Leukemia; Microtubule-Associated Proteins; Neoplasm Proteins; Paclitaxel; RNA, Antisense; Survivin; Tetrazolium Salts; Thiazoles | 2008 |
Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
Topics: Apoptosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Cell Separation; Female; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Molecular Sequence Data; Neoplasm Proteins; Ovarian Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-akt; RNA Interference; Survivin; Tetrazolium Salts; Thiazoles | 2009 |
Paclitaxel induces up-regulation of tissue factor in human aortic endothelial cells.
Topics: Antineoplastic Agents, Phytogenic; Aorta, Thoracic; Blotting, Western; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; In Vitro Techniques; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Thrombin; Thromboplastin; Up-Regulation | 2009 |
Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Orotate Phosphoribosyltransferase; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stomach Neoplasms; Taxoids; Tetrazolium Salts; Thiazoles | 2008 |
Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Doxorubicin; Drug Delivery Systems; Flow Cytometry; Humans; In Vitro Techniques; Lactic Acid; Paclitaxel; Polyesters; Polyethylene Glycols; Polymers; Rats; Technology, Pharmaceutical; Tetrazolium Salts; Thiazoles | 2009 |
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
Topics: Antineoplastic Agents; Benzamides; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Models, Chemical; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Piperazines; Pyrimidines; Tetrazolium Salts; Thiazoles | 2009 |
Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Blotting, Western; Cell Line, Tumor; Coloring Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tissue Distribution; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitory Concentration 50; MicroRNAs; Models, Biological; Paclitaxel; Phosphorylation; PTEN Phosphohydrolase; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles | 2010 |
Amyloid-β-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway.
Topics: Adenine Nucleotides; Amyloid beta-Peptides; Antineoplastic Agents, Phytogenic; Autophagy; Blotting, Western; Caspases; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Electron Transport Complex IV; Enzyme Activation; Humans; Lysosomes; Microscopy, Confocal; Microtubules; Mitochondrial Diseases; Mitochondrial Membranes; NAD; Paclitaxel; Peptide Fragments; Signal Transduction; Tetrazolium Salts; Thiazoles; Tubulin | 2011 |
PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coloring Agents; Delayed-Action Preparations; Diffusion; Drug-Eluting Stents; Female; Fluorouracil; Mice; Microscopy, Electron, Scanning; Paclitaxel; Polyesters; Polyethylene Glycols; Solubility; Spectrophotometry, Ultraviolet; Surface Properties; Tetrazolium Salts; Thiazoles; X-Ray Diffraction | 2012 |
Trojan-horse nanotube on-command intracellular drug delivery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Ceramides; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Materials Testing; Nanomedicine; Nanotechnology; Nanotubes; Paclitaxel; Pancreatic Neoplasms; RNA, Small Interfering; Solubility; Tetrazolium Salts; Thiazoles | 2012 |
Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug.
Topics: Anesthetics, Intravenous; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; In Situ Nick-End Labeling; Neoplasm Invasiveness; Ovarian Neoplasms; Paclitaxel; Propofol; Snail Family Transcription Factors; Tetrazolium Salts; Thiazoles; Transcription Factors | 2013 |
Silicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potential.
Topics: Antineoplastic Agents, Phytogenic; Cell Line; Cell Survival; Coloring Agents; Docetaxel; Drug Delivery Systems; Drug Design; Humans; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Indicators and Reagents; Kinetics; Models, Molecular; Molecular Conformation; Nanoparticles; Paclitaxel; Prodrugs; Silicates; Taxoids; Tetrazolium Salts; Thiazoles | 2014 |
Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Death; Cells, Cultured; Coloring Agents; Dendrimers; Drug Delivery Systems; Female; Gene Silencing; Genetic Vectors; Humans; Mice; Mice, Nude; Models, Molecular; Nanotechnology; Nuclease Protection Assays; Oncogene Protein v-akt; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; RNA, Small Interfering; Signal Transduction; Tetrazolium Salts; Thiazoles; Transfection | 2014 |
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
[Effect of estrogen or progesterone combined with paclitaxel on human ovarian cancer cell growth and Drosha expression].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Coloring Agents; Drug Therapy, Combination; Estrogens; Female; Humans; In Vitro Techniques; Ovarian Neoplasms; Paclitaxel; Progesterone; Receptors, Estrogen; Ribonuclease III; RNA, Messenger; Tetrazolium Salts; Thiazoles; Up-Regulation | 2015 |
Tumor-targeting and redox-sensitive micelles based on hyaluronic acid conjugate for delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hyaluronic Acid; In Vitro Techniques; MCF-7 Cells; Mice; Micelles; Microscopy, Electron, Transmission; Neoplasms; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Polymers; Rabbits; Tetrazolium Salts; Thiazoles; X-Ray Diffraction | 2020 |